XGenomes
YC W19Boston, US · Founded 2017 · 6 employees · 4 known investors
XGenomes develops genomic sequencing technology using fluorescent probes and machine learning to read genetic and epigenetic information at single-molecule resolution. The platform enables frequent, rapid, and low-cost screening for healthcare providers and patients to support early disease detection and personalized preventive medicine.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesGenomicsin /xgenomes/@ycombinator
Founders & leadership· Y Combinator alumni (W19)
Kalim MirinFounder/CEO
Investors · 4
In the news
- XGenomes - 2025 Funding Rounds & List of Investors - Tracxntracxn.com · 2021
- XGenomes - 2025 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Inside Cambridge Science Park’s new bio-powerhousecambridgeindependent.co.uk · 2020
- Massachusetts Life Sciences Center Awards Funding to Support Early-Stage Growth Across Major Sectors - MLSCmasslifesciences.com · 2019